These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18057430)

  • 1. Dosing of proton pump inhibitors in a private hospital in Hong Kong.
    Mui AC; Fan TC
    Hong Kong Med J; 2007 Dec; 13(6):430-5. PubMed ID: 18057430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The appropriateness of a proton pump inhibitor prescription.
    Moran N; Jones E; O'Toole A; Murray F
    Ir Med J; 2014; 107(10):326-7. PubMed ID: 25551900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards.
    van Vliet EP; Steyerberg EW; Otten HJ; Rudolphus A; Knoester PD; Hoogsteden HC; van Gelder T; Kuijpers PM; Siersema PD
    Aliment Pharmacol Ther; 2009 Jan; 29(2):213-21. PubMed ID: 19006542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation and duration of proton pump inhibitors in the Australian veteran population.
    Gadzhanova SV; Roughead EE; Mackson JM
    Intern Med J; 2012 May; 42(5):e68-73. PubMed ID: 20492006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study.
    Cheung KM; Tse PW; Ko CH; Chan YC; Leung CY; Chan KH
    Hong Kong Med J; 2001 Dec; 7(4):356-9. PubMed ID: 11773669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with guidelines for proton pump inhibitor prescriptions in a department of geriatrics.
    Seite F; Delelis-Fanien AS; Valero S; Pradère C; Poupet JY; Ingrand P; Paccalin M
    J Am Geriatr Soc; 2009 Nov; 57(11):2169-70. PubMed ID: 20121973
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice.
    Jarbøl DE; Lykkegaard J; Hansen JM; Munck A; Haastrup PF
    Fam Pract; 2019 Nov; 36(6):758-764. PubMed ID: 31165863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
    Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
    Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
    Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
    Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors are still overprescribed for hospitalized children.
    Arnoux A; Bailhache M; Tetard C; Rebouissoux L; Clouzeau H; Lamireau T; Enaud R
    Arch Pediatr; 2022 May; 29(4):258-262. PubMed ID: 35304031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease.
    Humayun F; Hoff PT; Robinson EA; Gunaratnam NT
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):936-941. PubMed ID: 18036424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.
    Franchi C; Mannucci PM; Nobili A; Ardoino I
    Eur J Clin Pharmacol; 2020 Mar; 76(3):459-465. PubMed ID: 31853593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor prescribing and costs in a large outpatient clinic.
    Hood W; McJunkin B; Warnock A; Girme A; Smith N; Robinson B
    W V Med J; 2014; 110(1):16-21. PubMed ID: 24640269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal use of proton pump inhibitors in primary care].
    Tack J; Louis E; Persy V; Urbain D
    Rev Med Liege; 2014 Mar; 69(3):139-45. PubMed ID: 24830213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate prescribing of proton pump inhibitors in hospitalized patients.
    Reid M; Keniston A; Heller JC; Miller M; Medvedev S; Albert RK
    J Hosp Med; 2012; 7(5):421-5. PubMed ID: 22190465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.